Splenic vein thrombosis diagnostic study of choice: Difference between revisions
| Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{Vbe}} | {{CMG}} ; {{AE}} {{Vbe}} | ||
==Overview== | ==Overview== | ||
The siagnostic study of choice for splenic vein thrombosis is | |||
== Diagnostic study of choice== | == Diagnostic study of choice== | ||
Revision as of 15:43, 16 January 2018
|
Splenic vein thrombosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Splenic vein thrombosis diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Splenic vein thrombosis diagnostic study of choice |
|
Splenic vein thrombosis diagnostic study of choice in the news |
|
Risk calculators and risk factors for Splenic vein thrombosis diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
The siagnostic study of choice for splenic vein thrombosis is
Diagnostic study of choice
Venous phase angiography accurately visualizes both the location of splenic vein obstruction and the routes of collateralization. This is a safer alternative than splenoportography, especially in patients with coagulopathy . The diagnosis of SVT is confirmed on angiography when selective injection of the splenic artery shows nonvisualization of the splenic vein on delayed images. Often venous collaterals in the splenic hilum and dilated gastroepiploic and short gastric veins are also seen